Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. The study involved 21 people whose disability due to MS had…

Details

Cell Surgical Network performs their first Ophthalmology deployment for Leber’s Optic Neuropathy

Board Certified Ophthalmologist Dr. David Milstein and CSN co-founder Dr. Elliot Lander. Cell Surgical Network performed their first Stromal Vascular Fraction (SVF) retrobulbar deployment for Leber’s optic neuropathy in our Rancho Mirage office. The patient is doing well and we are excited to see the long term benefits of CSN’s new Institutional Review Board (IRB) approved…

Details